Acquiring Company
Rocket Pharmaceuticals
Acquired Company
Renovacor, Inc.
New YorkGreenwhichBiotechnologyHealth CareGeneticsTherapeuticsBiotechnologyHealth CareGeneticsTherapeuticsDescription
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders with high unmet need, today announces that it has completed the previously announced acquisition of Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. Under the terms of the merger agreement entered into on September 19, 2022, Renovacor shareholders received, for each share of Renovacor common stock, 0.1763 shares of Rocket common stock.
Quick answer
Rocket Pharmaceuticals is acquiring Renovacor, Inc., announced December 1, 2022. Rocket Pharmaceuticals is based in New York, New York, United States.
- Who acquired Renovacor, Inc?
- Rocket Pharmaceuticals agreed to acquire Renovacor, Inc. on December 1, 2022.
- How much did Rocket Pharmaceuticals pay for Renovacor, Inc?
- The deal value was not disclosed.
- What does Rocket Pharmaceuticals do?
- Rocket Pharma (NASDAQ: RCKT) is a fully-integrated, clinical-stage company seeking gene therapy cures.
- Where are Rocket Pharmaceuticals and Renovacor, Inc. based?
- Rocket Pharmaceuticals is based in New York, New York, United States. Renovacor, Inc. is based in Greenwhich, Connecticut, United States.
- Who are the decision-makers at Rocket Pharmaceuticals?
- Fundz holds 1 contact at Rocket Pharmaceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Genetics and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Solid Biosciences Announces Closing Of Acquisition Of Aavantibio And Concurrent $75 Million Private Placement, $75M (December 5, 2022)
- Solid Biosciences Announces Stockholder Approval Of Acquisition Of Aavantibio (December 1, 2022)
- Prenetics Acquires Act Genomics, Creating A Leader In Comprehensive Cancer Genetics And Precision Oncology (December 16, 2022)
- Lilly Completes Acquisition Of Akouos Expanding Efforts To Help People With Genetic Diseases (December 1, 2022)
- Sonic Healthcare Acquires Strategic Stake In Microba Life Sciences, Establishes Significant Commercial Partnership (November 29, 2022)
- Atossa Therapeutics, Inc. To Acquire Stake In Privately Held Dynamic Cell Therapies As Part Of Overall Car-T Strategy (November 1, 2022)
Who to call at Rocket Pharmaceuticals, and when
When Rocket Pharmaceuticals changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Rocket Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Rocket Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Rocket Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Rocket Pharmaceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Renovacor, Inc.?
Renovacor, Inc. was acquired by Rocket Pharmaceuticals, based in New York. The deal was reported on December 1, 2022. Rocket Pharma (NASDAQ: RCKT) is a fully-integrated, clinical-stage company seeking gene therapy cures. Rocket Pharmaceuticals is publicly traded (RCKT) and operates in Biotechnology.
When did Rocket Pharmaceuticals acquire Renovacor, Inc.?
Rocket Pharmaceuticals's acquisition of Renovacor, Inc. was reported on December 1, 2022. Rocket Pharmaceuticals, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Renovacor, Inc. do?
Renovacor is a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It is privately held, operating in Biotechnology, and is based in Greenwhich.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.